Percutaneous Radio Frequency Ablation for Painful Skeletal Metastases

  • Matthew Callstrom
Reference work entry


Patients with skeletal metastatic disease often have inadequate pain relief and conventional treatments, including external beam radiation therapy and opioid analgesics, often fail to provide pain relief and when relief is obtained, the duration is often short. Side effects of conventional therapies may also markedly decrease their quality of life, and few options are available for pain relief in patients with painful bone metastases who fail standard treatments. Image-guided percutaneous radiofrequency ablation of focal painful metastases has emerged as an effective focal treatment for patients with painful metastatic disease. This treatment offers clinically significant reduction of pain, an improvement in their quality of life and reduction in the use of analgesic medications by these patients.


Conscious Sedation Ablation Margin Percutaneous Radiofrequency Ablation Focal Pain Percutaneous Cementoplasty 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Nielsen OS, Munro AJ, Tannock IF. Bone metastases: pathophysiology and management policy. J Clin Oncol. 1991;9:509–24.CrossRefPubMedGoogle Scholar
  2. 2.
    Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain. 1997;69(1–2):1–18.CrossRefPubMedGoogle Scholar
  3. 3.
    Coleman RE. Skeletal complications of malignancy. Cancer. 1997;80(8 Suppl):1588–94.CrossRefPubMedGoogle Scholar
  4. 4.
    Tubiana-Hulin M. Incidence, prevalence and distribution of bone metastases. Bone. 1991;12(Suppl 1):S9–10.CrossRefPubMedGoogle Scholar
  5. 5.
    Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the study by the radiation therapy oncology group. Cancer. 1982;50(5):893–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Steenland E, Leer JW, van Houwelingen H, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol. 1999;52(2):101–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Massie MJ, Holland JC. The cancer patient with pain: psychiatric complications and their management. J Pain Symptom Manage. 1992;7:99–109.CrossRefPubMedGoogle Scholar
  8. 8.
    Spiegel D, Sands S, Koopman C. Pain and depression in patients with cancer. Cancer. 1994;74:2570–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Jeremic B, Shibamoto Y, Acimovic L, et al. A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys. 1998;42(1):161–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Price P, Hoskin PJ, Easton D, Austin D, Palmer SG, Yarnold JR. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol. 1986;6(4):247–55.CrossRefPubMedGoogle Scholar
  11. 11.
    Cole DJ. A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases. Clin Oncol (R Coll Radiol). 1989;1:59–62.CrossRefGoogle Scholar
  12. 12.
    Gaze MN, Kelly CG, Kerr GR, et al. Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol. 1997;45(2):109–16.CrossRefPubMedGoogle Scholar
  13. 13.
    Hara S. Opioids for metastatic bone pain. Oncology. 2008;74(Suppl 1):52–4.CrossRefPubMedGoogle Scholar
  14. 14.
    Callstrom MR, York JD, Gaba RC, et al. Research reporting standards for image-guided ablation of bone and soft tissue tumors. J Vasc Interv Radiol. 2009;20(12):1527–40.CrossRefPubMedGoogle Scholar
  15. 15.
    Cho CH, Mathis JM, Ortiz O. Sacral fractures and sacroplasty. Neuroimaging Clin N Am. 2010;20(2):179–86.CrossRefPubMedGoogle Scholar
  16. 16.
    Sabharwal T, Katsanos K, Buy X, Gangi A. Image-guided ablation therapy of bone tumors. Semin Ultrasound CT MR. 2009;30(2):78–90.CrossRefPubMedGoogle Scholar
  17. 17.
    Lessard AM, Gilchrist J, Schaefer L, Dupuy DE. Palliation of recurrent Ewing sarcoma of the pelvis with cryoablation and somatosensory-evoked potentials. J Pediatr Hematol Oncol. 2009;31(1):18–21.CrossRefPubMedGoogle Scholar
  18. 18.
    Dupuy DE, Liu D, Hartfeil D, et al. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer. 2010;116(4):989–97.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Farrell MA, Charboneau JW, Callstrom MR, Reading CC, Engen DE, Blute ML. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. AJR Am J Roentgenol. 2003;181(5):1315–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Dupuy DE, Hong R, Oliver B, Goldberg SN. Radiofrequency ablation of spinal tumors: temperature distribution in the spinal canal. AJR. 2000;175:1263–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Honore P, Luger NM, Sabino MA, et al. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat Med. 2000;6(5):521–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Mannion RJ, Woolf CJ. Pain mechanisms and management: a central perspective. Clin J Pain. 2000;16:S144–56.CrossRefPubMedGoogle Scholar
  23. 23.
    Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol. 1997;121(3):417–24.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Gröenemeyer DHW, Schirp S, Gevargez A. Image-guided radiofrequency ablation of spinal tumors: preliminary experience with an expandable array electrode. Cancer J. 2002;8(1):33–9.CrossRefGoogle Scholar
  25. 25.
    Callstrom MR, Charboneau JW, Goetz MP, et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation. Radiology. 2002;224(1):87–97.CrossRefPubMedGoogle Scholar
  26. 26.
    Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004;22(2):300–6.CrossRefPubMedGoogle Scholar
  27. 27.
    Callstrom MR, Charboneau JW, Goetz MP, et al. Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol. 2006;35:1–15.CrossRefPubMedGoogle Scholar
  28. 28.
    Callstrom MR, Atwell TD, Charboneau JW, et al. Painful metastases involving bone: percutaneous image-guided cryoablation–prospective trial interim analysis. Radiology. 2006;241(2):572–80.CrossRefPubMedGoogle Scholar
  29. 29.
    Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin brief pain questionnaire to assess pain in cancer and other diseases. Pain. 1983;17:197–210.CrossRefPubMedGoogle Scholar
  30. 30.
    Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330:592–6.CrossRefPubMedGoogle Scholar
  31. 31.
    Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses. Am J Clin Oncol-Canc. 2007;30(4):361–7.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of RadiologyMayo ClinicRochesterUSA

Personalised recommendations